While these advantages have created much interest in the drug, the therapeutic potential of BCP as an alternative treatment strategy for T2DM needs to be further evaluated in controlled clinical studies, as does the efficacy and toxicity data of prolonged BCP treatment. This evidence concerns the gene OPN1SW and type 2 diabetes mellitus.